Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
PPARGC1B Antibody
NCTP01836
Description: Rabbit polyclonal to human PPARGC1B
Application: ELISA, WB
Reactivity: Human
Catalog #: NCTP01836
$360.00
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human |
| Isotype | IgG |
| Immunogen | A peptide corresponding to N region of human PPARGC1B protein. |
| Accession # | Q86YN6 |
| Alternative Names | ERRL1; PERC; PGC-1(beta); PGC1B; Peroxisome proliferator-activated receptor gamma coactivator 1-beta; PPAR-gamma coactivator 1-beta; PPARGC-1-beta; PGC-1-related estrogen receptor alpha coactivator; PGC1; PPARGC1; |
| Purification | Purified by antigen affinity column. |
| Formulation | Lyophilized power with 2% BSA and 0.02% NaN3 |
| Size | 100µg/200µl |
| APPLICATION | |
| ELISA | 1:10,000 – 1:100,000 |
| Western Blot | 1:200 – 1:2,000 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Wang L, Liu Q, Li F. et al. Apoptosis induced by PGC-1beta in breast cancer cells is mediated by the mTOR pathway. Oncol Rep. 30(4):1631-8 (2013). |